Table 1.
Pain Scores and Opioid Use Before and After Ketamine
| Variable | N (%) | |
|---|---|---|
| Sex | ||
| Female | 7 (31.8%) | |
| Male | 15 (68.2%) | |
| Age at admission | Average | 15.13 |
| Minimum | 9.42 | |
| Maximum | 20.42 | |
| Race/ethnicity | ||
| African American | 19 (86.4%) | |
| Hispanic | 3 (13.6%) | |
| Genotype | ||
| HbSS/HbSbeta0 | 21 (95.5%) | |
| HbSC | 1 (4.55%) | |
| Pain diagnosis | ||
| Recurrent acute pain | 16 (34.8%) | |
| Chronic pain | 30 (65.2%) | |
| Length of admission in days | ||
| Average | 6.5 | |
| Minimum | 2 | |
| Maximum | 15 | |
| Previous ketamine infusion | ||
| Yes | 22 (47.8%) | |
| No | 24 (52.2%) | |
| Additional medications | ||
| Hydroxyurea | 38 (82.6%) | |
| NSAIDs (ibuprofen, ketorolac) | 46 (95.7%) | |
| Acetaminophen | 37 (80.4%) | |
| Morphine | 28 (60.9%) | |
| Hydromorphone | 25 (54.3%) | |
| Acetaminophen/hydrocodone | 5 (10.9%) | |
| Oxycodone | 16 (34.8%) | |
| Gabapentin | 14 (30.4%) | |
| Methocarbamol | 17 (37%) | |
| Side effects * | ||
| Nausea | 8 (17.4%) | |
| Vomiting | 2 (4.3%) | |
| Sedation | 3 (6.5%) | |
| Hallucinations | 11 (23.9%) | |
| Dizziness | 8 (17.4%) | |
| Dyspnea | 0 (0%) | |
| Respiratory Depression | 0 (0%) | |
| Delirium | 0 (0%) | |
| Hypersensitivity Reaction | 0 (0%) | |
*
Patients may have experienced more than one side effect.